A 7-year-old boy with a 2-year history of episodic wheeze triggered by viral upper respiratory infections, exercise, and cold air presents to the pediatric clinic. Spirometry shows an obstructive pattern with FEV1/FVC ratio of 0.78. After administration of a short-acting beta-2 agonist via spacer, repeat spirometry shows FEV1 increase of 15% from baseline. The condition marked **A** in the diagram demonstrates this characteristic finding. Which of the following best describes the pathophysiological basis of the bronchodilator reversibility observed in this child?
A. Abnormal mucociliary clearance leading to progressive mucus plugging
B. Reversible smooth muscle contraction and airway inflammation responsive to bronchodilators, distinguishing asthma from fixed obstructive lesions
C. Vocal cord adduction during inspiration causing dynamic airway obstruction
D. Permanent structural remodeling of the bronchial wall with loss of elastic recoil
Explanation
Why "Reversible smooth muscle contraction and airway inflammation responsive to bronchodilators, distinguishing asthma from fixed obstructive lesions" is right
The clinical anchor defines pediatric asthma as a chronic inflammatory airway disease characterized by variable expiratory airflow limitation and bronchial hyperresponsiveness. The hallmark diagnostic feature in children ≥5–6 years is bronchodilator reversibility: a post-bronchodilator increase in FEV1 of ≥12% from baseline (percent-based in children due to smaller absolute volumes). This reversibility reflects the underlying pathophysiology—acute bronchoconstriction and airway inflammation that responds to smooth muscle relaxation by beta-2 agonists. This finding distinguishes asthma from fixed obstructive diseases (cystic fibrosis, tracheomalacia) where airway obstruction is structural and irreversible. The child's 15% FEV1 improvement after SABA administration is diagnostic of asthma and confirms the reversible nature of the obstruction (GINA 2024; Nelson Pediatrics 21e).
Why each distractor is wrong
Permanent structural remodeling of the bronchial wall with loss of elastic recoil: This describes fixed airway obstruction seen in advanced cystic fibrosis or chronic lung disease, not the reversible obstruction of asthma. Structural remodeling may occur with chronic poorly controlled asthma, but it is not the primary mechanism of bronchodilator reversibility.
Vocal cord adduction during inspiration causing dynamic airway obstruction: This is the pathophysiology of vocal cord dysfunction (marked C), which mimics asthma but does not show bronchodilator reversibility on spirometry and is not responsive to asthma medications.
Abnormal mucociliary clearance leading to progressive mucus plugging: This is characteristic of cystic fibrosis (marked B), where obstruction is due to thick secretions and structural bronchiectasis, not reversible smooth muscle contraction, and does not respond to bronchodilators.
High-YieldNEET PG
Bronchodilator reversibility (≥12% FEV1 increase in children) is the diagnostic hallmark of asthma and reflects reversible smooth muscle contraction—distinguishing it from fixed obstructive diseases like CF and tracheomalacia.
GINA 2024; Nelson Pediatrics 21e
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
